HOUSE  .  .  .  .  .  .  .  .  No. 4332

The Commonwealth of Massachusetts

________________________________________

HOUSE OF REPRESENTATIVES, July 31, 2025.

The committee on Financial Services, to whom was referred the petition (accompanied by bill, House, No. 1091) of Christine P. Barber relative to pharmacists as healthcare providers, reports recommending that the accompanying bill (House, No. 4332) ought to pass.

For the committee,

JAMES M. MURPHY.

        FILED ON: 7/25/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 4332

The Commonwealth of Massachusetts

_______________

In the One Hundred and Ninety-Fourth General Court
(2025-2026)

_______________

An Act relative to pharmacists as healthcare providers.

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

Chapter 94C is hereby amended by inserting, after section 19F, the following section:-

Section 19G. (a) Notwithstanding any general or special law to the contrary, a pharmacist may order, test, screen, and treat the following health conditions: influenza, streptococcal infections, COVID-19 or any other emerging and existing public health threats identified by the department if permitted by an order, rule, or regulation.

b) The department shall establish standard procedures for pharmacists to test, screen and initiate treatment for qualified health conditions.

(c) A pharmacist who orders, tests, screens, or treats health conditions under this section may use any test that may guide clinical decision making that is waived under the federal Clinical Laboratory Improvement Amendments of 1988, or the federal rules adopted thereunder, or any established screening procedure that is established via a statewide protocol.

(d) A pharmacist may delegate the administrative and technical tasks of performing a test waived by the federal Clinical Laboratory Improvement Amendments of 1988 to a pharmacy technician acting under the supervision of the pharmacist.

(e) This section prohibits the denial of reimbursement under health benefit plans for services and procedures performed by a pharmacist that are within the scope of the pharmacist’s license and would be covered if the services or procedures were performed by a physician, an advanced practice nurse, or physician's assistant. An insurance carrier or pharmacy benefit manager shall develop adequate provider and consult codes as authorized by this act for pharmacy compensation.